Bipolar disorder involves profound shifts between debilitating depression and euthymic states, presenting complex diagnostic and clinical management challenges. For decades, psychiatric research has focused on monoaminergic dysregulation to explain these cyclical transitions. In particular, the striatal dopamine transporter plays an essential role in modulating presynaptic reuptake and regulating extracellular dopamine concentrations. However, earlier cross-sectional neuroimaging studies could not clarify how presynaptic neurochemical fluctuations relate to large-scale connectomic reorganization across mood episodes within the same individual. Recent exploratory multimodal research now provides compelling longitudinal evidence demonstrating direct, state-dependent links between presynaptic transporter availability and functional brain networks.

The Neurobiology of Striatal Dopamine Transporter Dysregulation

Dopaminergic neurotransmission governs critical behavioral domains, including reward anticipation, motivation, and executive cognitive functioning. Consequently, aberrant dopamine signaling represents a foundational neurobiological hypothesis in bipolar illness. Clinical observations suggest that manic phases correspond to hyperdopaminergic states characterized by heightened dopamine release. Conversely, bipolar depressive episodes typically reflect hypodopaminergic transmission, producing profound apathy, anhedonia, and psychomotor deceleration. Within this regulatory architecture, the dopamine transporter acts as the principal gatekeeper controlling synaptic dopamine clearance. Therefore, alterations in transporter density directly dictate the concentration and residence duration of synaptic neurotransmitters. Although preclinical models suggested fluctuating transporter expression, human in vivo confirmation remained elusive. Past cross-sectional investigations yielded inconsistent results because substantial inter-individual variability and diverse medication regimens obscured true neurochemical differences. Furthermore, static assessments cannot capture the undulating trajectory of bipolar transitions over time. Multimodal neuroimaging now resolves these longstanding questions by tracking within-subject changes across distinct mood states. Thus, examining presynaptic transport kinetics clarifies how dopamine regulation fluctuates with clinical polarity.

Multimodal Imaging Protocol Across Clinical Mood States

To characterize these state-dependent dynamics, researchers conducted an exploratory longitudinal neuroimaging study involving thirty-three outpatients diagnosed with bipolar disorder. Specifically, investigators tracked participants prospectively across different clinical phases, completing paired imaging sessions during confirmed euthymic periods and acute depressive episodes. The team quantified presynaptic striatal dopamine transporter availability using 99mTc-TRODAT-1 single-photon emission computed tomography. Concurrently, participants underwent resting-state functional magnetic resonance imaging to capture intrinsic, whole-brain blood-oxygen-level-dependent signal fluctuations. Investigators defined seed regions within the dorsal striatum to map functional connectivity across widespread neocortical networks. Crucially, the experimental protocol excluded medications known to alter dopamine transporter binding, thereby protecting measurements against confounding pharmacodynamic interference. The research team applied paired statistical tests to evaluate within-individual changes across affective states. In addition, linear mixed-effects models analyzed state interactions between transporter availability and striatal connectivity, adjusting for participant age and biological sex. Consequently, this within-subject approach provided remarkable statistical robustness while successfully eliminating the confounding inter-individual variance that historically weakened psychiatric neuroimaging investigations.

Dynamic Shifts in Striatal Dopamine Transporter Availability

The neuroimaging analyses revealed marked state-dependent alterations in presynaptic dopaminergic architecture. Within individual participants, researchers demonstrated significantly lower bilateral dorsal striatal transporter availability during depression than during euthymia. This state-dependent reduction indicates dynamic presynaptic neurochemical reorganization during depressive episodes. Alternatively, diminished transporter availability may represent an endogenous compensatory mechanism that preserves declining extracellular dopamine during depressive lows. Importantly, this within-subject finding demonstrates that striatal transporter density is not a fixed, irreversible anatomical deficit. Instead, transporter availability changes dynamically in response to shifting clinical mood states. When patients achieved sustained euthymic remission, presynaptic transporter binding normalized, indicating substantial biological plasticity. Because the dorsal striatum regulates sensorimotor gating and cognitive flexibility, localized transporter alterations carry direct functional consequences. For instance, compromised dopamine regulation in dorsal striatal pathways likely produces characteristic psychomotor slowing and executive inertia. In contrast, euthymic recovery restores balanced monoaminergic turnover across striatal structures. Thus, these longitudinal observations confirm that dopamine transporter availability fluctuates dynamically with illness polarity.

Cortico-Striatal Network Reorganization Across Mood Episodes

Striatal dopamine signaling does not operate in isolation; rather, it coordinates extensive cortico-striatal and cortico-limbic functional loops. During euthymia, higher transporter availability correlated positively with robust functional connectivity between the dorsal striatum and the dorsal and middle cingulate cortices. These cingulate regions represent essential hubs within the salience and central executive networks. Consequently, strong striato-cingulate communication fosters adaptive emotional regulation, cognitive control, and flexible behavior in stable patients. In stark contrast, this adaptive connectivity pattern disintegrated when patients transitioned into depressive episodes. During depression, dorsal striatal transporter availability exhibited a pronounced negative association with connectivity to the precuneus. The precuneus serves as a central hub within the default mode network, which governs internally focused reflection and maladaptive rumination. Therefore, depressive neurochemistry redirects striatal connectivity away from executive networks and toward self-referential default mode loops. Furthermore, linear mixed-effects modeling confirmed state-dependent interactions involving the insular cortex and supramarginal gyrus. As a result, presynaptic dopaminergic downregulation decouples the striatum from sensory integration hubs, exacerbating cognitive inflexibility.

Clinical Correlations and Future Neurotherapeutic Implications

Crucially, the observed alterations in functional connectivity correlated directly with clinical symptom severity during depressive episodes. The researchers observed that reduced functional connectivity between the dorsal striatum and the anterior cingulate cortex tracked escalating depression scores. Similarly, diminished functional coupling between the dorsal striatum and the supramarginal gyrus predicted worse depressive symptom burden. Because the anterior cingulate cortex mediates conflict monitoring and motivated behavior, its detachment from striatal hubs exacerbates apathy and despair. Meanwhile, disconnection from the supramarginal gyrus likely impairs somatosensory processing and psychomotor execution. These robust correlations establish that functional connectivity shifts represent genuine neural correlates of illness severity rather than incidental imaging artifacts. Consequently, these findings offer valuable translational insights for contemporary clinical practice. Identifying state-dependent neurochemical and network alterations can facilitate more precise diagnostic stratification and guide personalized psychiatric therapies. For example, clinicians could monitor dopaminergic recovery or employ targeted neuromodulation to restore striato-cortical synchrony. Ultimately, multimodal neuroimaging bridges molecular pharmacology and connectomics, advancing precision medicine for bipolar disorder.

How does striatal dopamine transporter availability change across bipolar mood episodes?

Striatal dopamine transporter availability demonstrates significant state-dependent variation in individuals with bipolar disorder. Bilateral dorsal striatal transporter availability decreases significantly during depressive episodes compared to euthymia. Transporter availability normalizes when patients achieve clinical remission, demonstrating dynamic molecular plasticity rather than an unvarying biological deficit across affective phases.

Why is striato-cortical functional connectivity altered in bipolar depression?

During bipolar depression, reduced dopamine transporter availability decouples the dorsal striatum from executive regions, including the anterior cingulate cortex and supramarginal gyrus. Concurrently, connectivity shifts toward default mode nodes like the precuneus. This network breakdown disrupts emotional regulation and executive control, correlating directly with severe depressive symptoms.

What clinical value does multimodal neuroimaging offer in psychiatric practice?

Multimodal imaging combines molecular SPECT or PET radiotracers with resting-state functional MRI. This technique allows clinicians to simultaneously examine presynaptic neurotransmitter dynamics and large-scale brain network connectivity. By identifying objective biomarkers of mood state transitions, multimodal imaging supports targeted pharmacological strategies and refined neuromodulation protocols.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Huang MH et al. State-dependent associations between striatal dopamine transporter availability and large-scale functional networks in bipolar disorder: An exploratory multimodal imaging study. Asian J Psychiatr. 2026 Oct. doi: 10.1016/j.ajp.2026.105137. PMID: 42659872.


2. Anand A, Barkay G, Dzemidzic M, et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord. 2011;13(4):397-403. doi: 10.1111/j.1399-5618.2011.00936.x.


3. Ashok AH, Marques TR, Jauhar S, et al. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for therapy. Mol Psychiatry. 2017;22(5):666-679. doi: 10.1038/mp.2017.16.